These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17361757)

  • 1. [Uveitis immunopathology: currents knowledge, clinical correlation and research perspectives in the immue-ocular area].
    Jiménez Martínez MC; Carrera I; Pedroza Seres M; Jaimes M; Schlaen A; Garfias Y
    Rev Alerg Mex; 2006; 53(6):226-35. PubMed ID: 17361757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications.
    Nussenblatt RB
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3131-41. PubMed ID: 1748544
    [No Abstract]   [Full Text] [Related]  

  • 3. Regional immunity of the eye.
    Mochizuki M
    Acta Ophthalmol; 2010 May; 88(3):292-9. PubMed ID: 19900207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental microbes and uveitis: is microbial exposure always bad?
    Massilamany C; Gangaplara A; Reddy J
    Scand J Immunol; 2015 Jun; 81(6):469-75. PubMed ID: 25833717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenic mechanisms in intraocular inflammation.
    Forrester JV; McMenamin PG
    Chem Immunol; 1999; 73():159-85. PubMed ID: 10590579
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of T cells in autoimmune uveitis.
    Becker MD; Adamus G; Davey MP; Rosenbaum JT
    Ocul Immunol Inflamm; 2000 Jun; 8(2):93-100. PubMed ID: 10980681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of retinal autoantigens and their peptides on the inhibition of experimental autoimmune uveitis.
    Dua HS; Abrams MS; Barrett JA; Donoso LA
    Eye (Lond); 1992; 6 ( Pt 5)():447-52. PubMed ID: 1286703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uveitis].
    Brézin AP
    Presse Med; 2012 Jan; 41(1):10-20. PubMed ID: 21724361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)].
    Sugiura S
    Nippon Ganka Gakkai Zasshi; 1976 Nov; 80(11):1285-326. PubMed ID: 1034425
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity in the eye and its regulation.
    Gery I; Streilein JW
    Curr Opin Immunol; 1994 Dec; 6(6):938-45. PubMed ID: 7710718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune tolerance and autoimmune uveoretinitis: the role of the ocular microenvironment.
    Takeuchi M
    Immunotherapy; 2011 Sep; 3(9):1103-11. PubMed ID: 21913832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
    Taylor AW; Kaplan HJ
    Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunology in clinical practice. XIII. Immune diseases of the eye].
    Ooijman FM; van der Lelij A
    Ned Tijdschr Geneeskd; 1998 Feb; 142(9):443-8. PubMed ID: 9562756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
    Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
    Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple etiologies of equine recurrent uveitis--A natural model for human autoimmune uveitis: A brief review.
    Witkowski L; Cywinska A; Paschalis-Trela K; Crisman M; Kita J
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():14-20. PubMed ID: 26851589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of experimental autoimmune uveitis using a rat anti retinal S-antigen specific monoclonal antibody: evidence for a species difference.
    Dua HS; Liversidge J; Forrester JV
    Eye (Lond); 1989; 3 ( Pt 1)():69-78. PubMed ID: 2591601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
    Dong Z; Iwata D; Kitaichi N; Takeuchi M; Sato M; Endo N; Iwabuchi K; Ando R; Fukuhara J; Kinoshita S; Lennikov A; Kitamura M; Mizuuchi K; Kanda A; Noda K; Namba K; Yamagishi S; Ohno S; Ishida S
    J Leukoc Biol; 2014 Dec; 96(6):1077-85. PubMed ID: 25201803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.